Immune-mediated red cell aplasia after anti-CTLA-4 immunotherapy for metastatic melanoma

Cancer Immunol Immunother. 2009 Aug;58(8):1351-3. doi: 10.1007/s00262-008-0627-x. Epub 2008 Dec 4.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antibodies, Monoclonal / administration & dosage
  • Antibodies, Monoclonal / adverse effects*
  • Antibodies, Monoclonal / therapeutic use
  • Antigens, CD / immunology
  • CTLA-4 Antigen
  • Humans
  • Immunotherapy / adverse effects*
  • Ipilimumab
  • Male
  • Melanoma / therapy*
  • Middle Aged
  • Red-Cell Aplasia, Pure / diagnosis*
  • Red-Cell Aplasia, Pure / immunology*

Substances

  • Antibodies, Monoclonal
  • Antigens, CD
  • CTLA-4 Antigen
  • CTLA4 protein, human
  • Ipilimumab